Compound Detail
CHEMBL148201
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL148201 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | AWALKBINULQLLD-UHFFFAOYSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
543.7
MW (Da)
7.21
ALogP
4
HBA
2
HBD
58.6
PSA (Ų)
0.11
QED
2
Ro5 Violations
14
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 6.14
IC50 1 meas. best 6.14
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| ATP-dependent translocase ABCB1 CHEMBL4302 | EC50 | 6.14 | 6.14 | 723.0 | 1 |
| CCRF-CEM/VCR-1000 CHEMBL614540 | IC50 | 6.14 | 6.14 | 720.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| ATP-dependent translocase ABCB1 | EC50 | = | 723.0 | nM | 6.14 | Inhibition of P-glycoprotein expressed in MDR CCRF vcr1000 cells by daunorubicin... | 17352460 |
| CCRF-CEM/VCR-1000 | IC50 | = | 720.0 | nM | 6.14 | In vitro multi drug resistance (MDR) reversal inhibitory activity against CCRF-C... | 14584949 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 14584949 | 10.1021/jm030876r | No relevant target | 2 |
| 14584949 | 10.1021/jm030876r | CCRF-CEM/VCR-1000 | 1 |
| 17352460 | 10.1021/jm060604z | ATP-dependent translocase ABCB1 | 1 |
Data from ChEMBL 36 via Core Engine